Search hospitals

>

Massachusetts

>

Boston

Boston Medical Center

Claim this profile

Boston, Massachusetts 02118

Global Leader in HIV Infection

Global Leader in Lung Cancer

Conducts research for Breast Cancer

Conducts research for Human Immunodeficiency Virus Infection

Conducts research for Stroke

827 reported clinical trials

81 medical researchers

Photo of Boston Medical Center in BostonPhoto of Boston Medical Center in BostonPhoto of Boston Medical Center in Boston

Summary

Boston Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of HIV Infection, Lung Cancer, Breast Cancer, Human Immunodeficiency Virus Infection, Stroke and other specialties. Boston Medical Center is involved with conducting 827 clinical trials across 1,130 conditions. There are 81 research doctors associated with this hospital, such as Umit Tapan, MD, M B, Hussein Assi, and Vaishali Sanchorawala, MD.

Area of expertise

1

HIV Infection

Global Leader

Boston Medical Center has run 66 trials for HIV Infection. Some of their research focus areas include:

Stage II
Stage III
Stage IV
2

Lung Cancer

Global Leader

Boston Medical Center has run 58 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive

Top PIs

Clinical Trials running at Boston Medical Center

Breast Cancer

Lung Cancer

Breast cancer

Amyloidosis

Stroke

Cancer

Lazy Eye

Small Cell Lung Cancer

Pancreatic Cancer

Colorectal Cancer

Image of trial facility.

Gadolinium-Based Contrast Media Effects on Motor and Cognitive Functioning

for

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.

Recruiting

3 awards

Phase 4

9 criteria

Image of trial facility.

Sacituzumab Govitecan + Talazoparib

for Breast Cancer

This research is studying the effect of Antibody-Drug Conjugate Sacituzumab Govitecan in Combination with the Poly (Adenosine Diphosphate \[ADP\]-Ribose) Polymerase (PARP) Inhibitor Talazoparib in Patients with Metastatic Triple-Negative Breast Cancer.

Recruiting

3 awards

Phase 1 & 2

11 criteria

Image of trial facility.

Elacestrant

for Breast Cancer

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Recruiting

2 awards

Phase 3

3 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Boston Medical Center?

Where is Boston Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Boston Medical Center accept?

What awards or recognition has Boston Medical Center received?